Identification of a Distinct Type IV Collagen a Chain with Restricted
Total Page:16
File Type:pdf, Size:1020Kb
Load more
Recommended publications
-
Repair, Regeneration, and Fibrosis Gregory C
91731_ch03 12/8/06 7:33 PM Page 71 3 Repair, Regeneration, and Fibrosis Gregory C. Sephel Stephen C. Woodward The Basic Processes of Healing Regeneration Migration of Cells Stem cells Extracellular Matrix Cell Proliferation Remodeling Conditions That Modify Repair Cell Proliferation Local Factors Repair Repair Patterns Repair and Regeneration Suboptimal Wound Repair Wound Healing bservations regarding the repair of wounds (i.e., wound architecture are unaltered. Thus, wounds that do not heal may re- healing) date to physicians in ancient Egypt and battle flect excess proteinase activity, decreased matrix accumulation, Osurgeons in classic Greece. The liver’s ability to regenerate or altered matrix assembly. Conversely, fibrosis and scarring forms the basis of the Greek myth involving Prometheus. The may result from reduced proteinase activity or increased matrix clotting of blood to prevent exsanguination was recognized as accumulation. Whereas the formation of new collagen during the first necessary event in wound healing. At the time of the repair is required for increased strength of the healing site, American Civil War, the development of “laudable pus” in chronic fibrosis is a major component of diseases that involve wounds was thought to be necessary, and its emergence was not chronic injury. appreciated as a symptom of infection but considered a positive sign in the healing process. Later studies of wound infection led The Basic Processes of Healing to the discovery that inflammatory cells are primary actors in the repair process. Although scurvy (see Chapter 8) was described in Many of the basic cellular and molecular mechanisms necessary the 16th century by the British navy, it was not until the 20th for wound healing are found in other processes involving dynamic century that vitamin C (ascorbic acid) was found to be necessary tissue changes, such as development and tumor growth. -
Alport Syndrome of the European Dialysis Population Suffers from AS [26], and Simi- Lar Figures Have Been Found in Other Series
DOCTOR OF MEDICAL SCIENCE Patients with AS constitute 2.3% (11/476) of the renal transplant population at the Mayo Clinic [24], and 1.3% of 1,000 consecutive kidney transplant patients from Sweden [25]. Approximately 0.56% Alport syndrome of the European dialysis population suffers from AS [26], and simi- lar figures have been found in other series. AS accounts for 18% of Molecular genetic aspects the patients undergoing dialysis or having received a kidney graft in 2003 in French Polynesia [27]. A common founder mutation was in Jens Michael Hertz this area. In Denmark, the percentage of patients with AS among all patients starting treatment for ESRD ranges from 0 to 1.21% (mean: 0.42%) in a twelve year period from 1990 to 2001 (Danish National This review has been accepted as a thesis together with nine previously pub- Registry. Report on Dialysis and Transplantation in Denmark 2001). lished papers by the University of Aarhus, February 5, 2009, and defended on This is probably an underestimate due to the difficulties of establish- May 15, 2009. ing the diagnosis. Department of Clinical Genetics, Aarhus University Hospital, and Faculty of Health Sciences, Aarhus University, Denmark. 1.3 CLINICAL FEATURES OF X-LINKED AS Correspondence: Klinisk Genetisk Afdeling, Århus Sygehus, Århus Univer- 1.3.1 Renal features sitetshospital, Nørrebrogade 44, 8000 Århus C, Denmark. AS in its classic form is a hereditary nephropathy associated with E-mail: [email protected] sensorineural hearing loss and ocular manifestations. The charac- Official opponents: Lisbeth Tranebjærg, Allan Meldgaard Lund, and Torben teristic renal features in AS are persistent microscopic hematuria ap- F. -
The Ehlers–Danlos Syndromes
PRIMER The Ehlers–Danlos syndromes Fransiska Malfait1 ✉ , Marco Castori2, Clair A. Francomano3, Cecilia Giunta4, Tomoki Kosho5 and Peter H. Byers6 Abstract | The Ehlers–Danlos syndromes (EDS) are a heterogeneous group of hereditary disorders of connective tissue, with common features including joint hypermobility, soft and hyperextensible skin, abnormal wound healing and easy bruising. Fourteen different types of EDS are recognized, of which the molecular cause is known for 13 types. These types are caused by variants in 20 different genes, the majority of which encode the fibrillar collagen types I, III and V, modifying or processing enzymes for those proteins, and enzymes that can modify glycosaminoglycan chains of proteoglycans. For the hypermobile type of EDS, the molecular underpinnings remain unknown. As connective tissue is ubiquitously distributed throughout the body, manifestations of the different types of EDS are present, to varying degrees, in virtually every organ system. This can make these disorders particularly challenging to diagnose and manage. Management consists of a care team responsible for surveillance of major and organ-specific complications (for example, arterial aneurysm and dissection), integrated physical medicine and rehabilitation. No specific medical or genetic therapies are available for any type of EDS. The Ehlers–Danlos syndromes (EDS) comprise a genet six EDS types, denominated by a descriptive name6. The ically heterogeneous group of heritable conditions that most recent classification, the revised EDS classification in share several clinical features, such as soft and hyper 2017 (Table 1) identified 13 distinct clinical EDS types that extensible skin, abnormal wound healing, easy bruising are caused by alterations in 19 genes7. -
Genetic Disorder
Genetic disorder Single gene disorder Prevalence of some single gene disorders[citation needed] A single gene disorder is the result of a single mutated gene. Disorder Prevalence (approximate) There are estimated to be over 4000 human diseases caused Autosomal dominant by single gene defects. Single gene disorders can be passed Familial hypercholesterolemia 1 in 500 on to subsequent generations in several ways. Genomic Polycystic kidney disease 1 in 1250 imprinting and uniparental disomy, however, may affect Hereditary spherocytosis 1 in 5,000 inheritance patterns. The divisions between recessive [2] Marfan syndrome 1 in 4,000 and dominant types are not "hard and fast" although the [3] Huntington disease 1 in 15,000 divisions between autosomal and X-linked types are (since Autosomal recessive the latter types are distinguished purely based on 1 in 625 the chromosomal location of Sickle cell anemia the gene). For example, (African Americans) achondroplasia is typically 1 in 2,000 considered a dominant Cystic fibrosis disorder, but children with two (Caucasians) genes for achondroplasia have a severe skeletal disorder that 1 in 3,000 Tay-Sachs disease achondroplasics could be (American Jews) viewed as carriers of. Sickle- cell anemia is also considered a Phenylketonuria 1 in 12,000 recessive condition, but heterozygous carriers have Mucopolysaccharidoses 1 in 25,000 increased immunity to malaria in early childhood, which could Glycogen storage diseases 1 in 50,000 be described as a related [citation needed] dominant condition. Galactosemia -
Adenovirus-Mediated Transfer of Type IV Collagen Α5 Chain Cdna
Gene Therapy (2001) 8, 882–890 2001 Nature Publishing Group All rights reserved 0969-7128/01 $15.00 www.nature.com/gt RESEARCH ARTICLE Adenovirus-mediated transfer of type IV collagen ␣5 chain cDNA into swine kidney in vivo: deposition of the protein into the glomerular basement membrane P Heikkila¨1, A Tibell2, T Morita1, Y Chen1,GWu2, Y Sado4, Y Ninomiya5, E Pettersson3 and K Tryggvason1 1Division of Matrix Biology, Department of Medical Biochemistry and Biophysics, Departments of 2Transplantation Surgery, and 3Nephrology, Huddinge Hospital, Karolinska Institutet, Stockholm, Sweden; 4Division of Immunology, Shigei Medical Research Institute, Okayama; 5Department of Molecular Biology and Biochemistry, Okayama University Medical School, Okayama, Japan Gene therapy of Alport syndrome (hereditary nephritis) aims a FLAG epitope in the recombinant ␣5(IV) chain. The results at the transfer of a corrected type IV collagen ␣ chain gene indicate that correction of the molecular defect in Alport syn- into renal glomerular cells responsible for production of the drome is possible. Previously, we had developed an organ glomerular basement membrane (GBM). A GBM network perfusion method for effective in vivo gene transfer into composed of type IV collagen molecules is abnormal in glomerular cells. In vivo perfusion of pig kidneys with the Alport syndrome which leads progressively to kidney failure. recombinant adenovirus resulted in expression of the ␣5(IV) The most common X-linked form of the disease is caused chain in kidney glomeruli as shown by in situ hybridization by mutations in the gene for the ␣5(IV) chain, the ␣5 chain and its deposition into the GBM was shown by immunohisto- of type IV collagen. -
Premature Aggregation of Type IV Collagen and Early Lethality in Lysyl Hydroxylase 3 Null Mice
Premature aggregation of type IV collagen and early lethality in lysyl hydroxylase 3 null mice Kati Rautavuoma*†‡, Kati Takaluoma*†‡, Raija Sormunen§, Johanna Myllyharju*†, Kari I. Kivirikko*†, and Raija Soininen†¶ *Collagen Research Unit and Departments of †Medical Biochemistry and Molecular Biology and §Pathology, Biocenter Oulu, University of Oulu, 90014 Oulu, Finland Edited by Erkki Ruoslahti, The Burnham Institute, La Jolla, CA, and approved August 17, 2004 (received for review July 9, 2004) Collagens carry hydroxylysine residues that act as attachment sites LH3 is essential for the synthesis of type IV collagen during early for carbohydrate units and are important for the stability of development and, hence, for the stability of basement mem- crosslinks but have been regarded as nonessential for vertebrate branes (BMs). survival. We generated mice with targeted inactivation of the gene for one of the three lysyl hydroxylase isoenzymes, LH3. The null Materials and Methods embryos developed seemingly normally until embryonic day 8.5, Targeting of the Plod3 Gene and Generation of Mutant Mice. The but development was then retarded, with death around embryonic genomic clone used to clone the targeting construct was isolated day 9.5. Electron microscopy (EM) revealed fragmentation of base- from a 129SV mouse genomic library with human LH3 cDNA ment membranes (BMs), and immuno-EM detected type IV collagen (5) as a probe. The construct contains 1.2- and 5-kb genomic within the dilated endoplasmic reticulum and in extracellular arms and the -gal-PGK-neo cassette inserted in-frame into exon aggregates, but the typical BM staining was absent. Amorphous 1. Embryonic stem cells were targeted, and mice were generated intracellular and extracellular particles were also seen by collagen by standard techniques. -
Ehlers-Danlos Syndrome Type VI in a 17-Year-Old Iranian Boy with Severe Muscular Weakness – a Diagnostic Challenge?
Iran J Pediatr Case Report Sep 2010; Vol 20 (No 3), Pp: 358-362 Ehlers-Danlos Syndrome Type VI in a 17-Year-Old Iranian Boy with Severe Muscular Weakness – A Diagnostic Challenge? Ariana Kariminejad*1, MD; Bita Bozorgmehr1, MD; Alireza Khatami2; MD; Mohamad-Hasan Kariminejad1, MD; Cecilia Giunta3, MD, and Beat Steinmann3, MD 1. Kariminejad Najmabadi Pathology and Genetics Center, Tehran, IR Iran 2. Mofid Children's Hospital, Shahid Beheshti University of Medical Sciences, Tehran, IR Iran 3. Division of Metabolism and Molecular Pediatrics, University Children's Hospital Zurich, Switzerland Received: May 20, 2009; Final Revision: Nov 14, 2009; Accepted: Jan 18, 2010 Abstract Background: The Ehlers-Danlos syndrome type VI (EDSVI) is an autosomal recessive connective tissue disease which is characterized by severe hypotonia at birth, progressive kyphoscoliosis, skin hyperelasticity and fragility, joint hypermobility and (sub-)luxations, microcornea, rupture of arteries and the eye globe, and osteopenia. The enzyme collagen lysyl hydroxylase (LH1) is deficient in these patients due to mutations in the PLOD1 gene. Case Presentation: We report a 17-year-old boy, born to related parents, with severe kyphoscoliosis, scar formation, joint hypermobility and multiple dislocations, muscular weakness, rupture of an ocular globe, and a history of severe infantile hypotonia. EDS VI was suspected clinically and confirmed by an elevated ratio of urinary total lysyl pyridinoline to hydroxylysyl pyridinoline, abnormal electrophoretic mobility of the α-collagen chains, and mutation analysis. Conclusion: Because of the high rate of consanguineous marriages in Iran and, as a consequence thereof, an increased rate of autosomal recessive disorders, we urge physicians to consider EDS VI in the differential diagnosis of severe infantile hypotonia and muscular weakness, a disorder which can easily be confirmed by the analysis of urinary pyridinolines that is highly specific, sensitive, robust, fast, non-invasive, and inexpensive. -
Original Article Glycation of Matrix Proteins in the Artery Inhibits Migration of Smooth Muscle Cells from the Media to the Intima
Original Article Glycation of Matrix Proteins in the Artery Inhibits Migration of Smooth Muscle Cells from the Media to the Intima (glycation / advanced glycation end products / collagen / elastin / myocytes / atherosclerosis) A. KUZAN1, O. MICHEL1, A. GAMIAN1,2 1Department of Medical Biochemistry, Wroclaw Medical University, Wrocław, Poland 2Laboratory of Medical Microbiology, Ludwik Hirszfeld Institute of Immunology and Experimental Therapy, Polish Academy of Sciences, Wroclaw, Poland Abstract. Formation and growth of atherosclerotic Introduction plaques have serious clinical consequences. One mechanism that occurs during atherogenesis is mi- Smooth muscle cells (SMC) are predominantly lo- gration of smooth muscle cells from the middle layer cated in the middle layer of the artery, where they play a of the artery to the intima, where they proliferate crucial role: they determine the contractility of the tis- and are transformed into foam cells. This degenera- sue, hereby adjusting the blood flow through the artery. tive process is accompanied by glycation, by which In such a case, they are called contractile smooth muscle proteins are modified and change the biomechanical cells, which are characterized by the richness in actin and biochemical properties. The aim of the study filaments. They may, however, undergo phenotype was to determine whether glycation of collagen and switching and migration and become cells that reside in elastin building the walls of blood vessels alters the the intima. Then, they are called synthetic type SMC, adhesion and rate of myocyte migration. In vitro ex- are rich in rough endoplasmic reticulum and character- periments included migration assays and immuno- ized by active metabolism (Stary et al., 1992, 1994; cytochemical staining with anti α-actin, β-catenin Tukaj, 2010). -
Type IV Collagens and Basement Membrane Diseases: Cell Biology and Pathogenic Mechanisms
CHAPTER THREE Type IV Collagens and Basement Membrane Diseases: Cell Biology and Pathogenic Mechanisms Mao Mao, Marcel V. Alavi, Cassandre Labelle-Dumais and Douglas B. Gould* Departments of Ophthalmology and Anatomy, Institute for Human Genetics, UCSF School of Medicine, San Francisco, CA, USA *Corresponding author: E-mail: [email protected] Contents 1. Genomic Organization and Protein Structure of Type IV Collagens 62 1.1 Introduction and history 62 1.2 Genomic structure 64 1.3 Protein domain structure 66 1.3.1 7S domain 68 1.3.2 Triple helical domain 69 1.3.3 NC1 domain 70 2. Type IV Collagen Biosynthesis 72 2.1 Heat shock protein 47 72 2.2 Protein disulfide isomerase 73 2.3 Peptidylprolyl isomerases 74 2.4 Prolyl 4-hydroxylases 74 2.5 Prolyl 3-hydroxylases 75 2.6 Lysyl hydroxylases 76 2.7 Transport and Golgi organization 1 78 3. Type IV Collagen-Related Pathology 78 3.1 COL4A3eA6-associated pathology 78 3.1.1 Goodpasture disease 78 3.1.2 Alport syndrome 79 3.2 COL4A1/COL4A2-associated pathology 81 3.2.1 Ocular dysgenesis 81 3.2.2 Porencephaly 82 3.2.3 Small vessel disease 83 3.2.4 Cerebral cortical lamination defects 84 3.2.5 Myopathy 85 3.2.6 HANAC syndrome and nephropathy 85 4. Mechanisms for Type IV Collagen-Related Pathology 86 4.1 Overview 86 Current Topics in Membranes, Volume 76 ISSN 1063-5823 © 2015 Elsevier Inc. http://dx.doi.org/10.1016/bs.ctm.2015.09.002 All rights reserved. 61 j 62 Mao Mao et al. -
Collagens—Structure, Function, and Biosynthesis
View metadata, citation and similar papers at core.ac.uk brought to you by CORE provided by University of East Anglia digital repository Advanced Drug Delivery Reviews 55 (2003) 1531–1546 www.elsevier.com/locate/addr Collagens—structure, function, and biosynthesis K. Gelsea,E.Po¨schlb, T. Aignera,* a Cartilage Research, Department of Pathology, University of Erlangen-Nu¨rnberg, Krankenhausstr. 8-10, D-91054 Erlangen, Germany b Department of Experimental Medicine I, University of Erlangen-Nu¨rnberg, 91054 Erlangen, Germany Received 20 January 2003; accepted 26 August 2003 Abstract The extracellular matrix represents a complex alloy of variable members of diverse protein families defining structural integrity and various physiological functions. The most abundant family is the collagens with more than 20 different collagen types identified so far. Collagens are centrally involved in the formation of fibrillar and microfibrillar networks of the extracellular matrix, basement membranes as well as other structures of the extracellular matrix. This review focuses on the distribution and function of various collagen types in different tissues. It introduces their basic structural subunits and points out major steps in the biosynthesis and supramolecular processing of fibrillar collagens as prototypical members of this protein family. A final outlook indicates the importance of different collagen types not only for the understanding of collagen-related diseases, but also as a basis for the therapeutical use of members of this protein family discussed in other chapters of this issue. D 2003 Elsevier B.V. All rights reserved. Keywords: Collagen; Extracellular matrix; Fibrillogenesis; Connective tissue Contents 1. Collagens—general introduction ............................................. 1532 2. Collagens—the basic structural module......................................... -
Characterization of a Type IV Collagen Major Cell Binding Site with Affinity to the Cd
View metadata, citation and similar papers at core.ac.uk brought to you by CORE provided by PubMed Central Characterization of a Type IV Collagen Major Cell Binding Site with Affinity to the cd/ l and the a2 1 Integrins Philipp Vandenberg, Andreas Kern, Albert Ries, Louise Luckenbill-Edds, Karlheinz Mann, and Klaus Kiilm Max-Planck-Institut f/Jr Biochemie, D-8033 Martinsried, Germany Abstract. The aim of this investigation was to identify closer investigation of the binding site. The smallest, the domains of type IV collagen participating in cell fully active triple-helical fragment was (150)3-amino binding and the cell surface receptor involved. A ma- acid residues long. It contained segments of 27 and 37 jor cell binding site was found in the trimeric cyanogen residues, respectively, at the NHe and COOH terminus, bromide-derived fragment CB3, located 100 nm away which proved to be essential for cell binding. from the NH: terminus of the molecule, in which the By affinity chromatography on Sepharose-immobilized triple-helical conformation is stabilized by interchain CB3, two receptor molecules of the integrin family, otl/31 disulfide bridges. Cell attachment assays with type IV and oe2/$1, were isolated. Their subunits were identified collagen and CB3 revealed comparable cell binding ac- by sequencing the NH2 termini or by immunoblotting. tivities. Antibodies against CB3 inhibited attachment The availability of fragment CB3 will allow for a more on fragment CB3 completely and on type IV collagen in-depth study of the molecular interaction of a short, to 80%. The ability to bind cells was strictly confor- well defined triple-helical ligand with collagen recep- mation dependent. -
An Access-Dictionary of Internationalist High Tech Latinate English
An Access-Dictionary of Internationalist High Tech Latinate English Excerpted from Word Power, Public Speaking Confidence, and Dictionary-Based Learning, Copyright © 2007 by Robert Oliphant, columnist, Education News Author of The Latin-Old English Glossary in British Museum MS 3376 (Mouton, 1966) and A Piano for Mrs. Cimino (Prentice Hall, 1980) INTRODUCTION Strictly speaking, this is simply a list of technical terms: 30,680 of them presented in an alphabetical sequence of 52 professional subject fields ranging from Aeronautics to Zoology. Practically considered, though, every item on the list can be quickly accessed in the Random House Webster’s Unabridged Dictionary (RHU), updated second edition of 2007, or in its CD – ROM WordGenius® version. So what’s here is actually an in-depth learning tool for mastering the basic vocabularies of what today can fairly be called American-Pronunciation Internationalist High Tech Latinate English. Dictionary authority. This list, by virtue of its dictionary link, has far more authority than a conventional professional-subject glossary, even the one offered online by the University of Maryland Medical Center. American dictionaries, after all, have always assigned their technical terms to professional experts in specific fields, identified those experts in print, and in effect held them responsible for the accuracy and comprehensiveness of each entry. Even more important, the entries themselves offer learners a complete sketch of each target word (headword). Memorization. For professionals, memorization is a basic career requirement. Any physician will tell you how much of it is called for in medical school and how hard it is, thanks to thousands of strange, exotic shapes like <myocardium> that have to be taken apart in the mind and reassembled like pieces of an unpronounceable jigsaw puzzle.